Cargando…
Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age
Incidence and neonatal risk factors for short stature in preterm children born small for gestational age (SGA) have not been fully investigated in Japan. In this prospective study, infants born ≤32 weeks’ gestational age (GA) from 2004–2015 were enrolled and followed for 3 years. Incidence of short...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706397/ https://www.ncbi.nlm.nih.gov/pubmed/31439925 http://dx.doi.org/10.1038/s41598-019-48785-y |
_version_ | 1783445692771991552 |
---|---|
author | Matsumoto, Masaaki Nagano, Nobuhiko Awano, Hiroyuki Ohyama, Shohei Fujioka, Kazumichi Iwatani, Sota Urakami, Tatsuhiko Iijima, Kazumoto Morioka, Ichiro |
author_facet | Matsumoto, Masaaki Nagano, Nobuhiko Awano, Hiroyuki Ohyama, Shohei Fujioka, Kazumichi Iwatani, Sota Urakami, Tatsuhiko Iijima, Kazumoto Morioka, Ichiro |
author_sort | Matsumoto, Masaaki |
collection | PubMed |
description | Incidence and neonatal risk factors for short stature in preterm children born small for gestational age (SGA) have not been fully investigated in Japan. In this prospective study, infants born ≤32 weeks’ gestational age (GA) from 2004–2015 were enrolled and followed for 3 years. Incidence of short children born SGA and short stature treated with growth hormone (GH) were investigated. Neonatal risk factors were analysed using univariate and multivariate analyses. GA cut-off value was determined using receiver operating characteristic (ROC) curve analyses. Of 604 infants born ≤32 weeks’ GA, 76 (13%) were SGA at birth. Twenty-seven infants (36%) developed short stature at age 2 and 14 infants (19%) received GH treatment at age 3. GA, birthweight, birth length, birth head circumference, and chronic lung disease at 36 weeks’ corrected GA were determined as risk factors by univariate analyses (p < 0.01). Multivariate analyses only revealed low GA as an independent risk factor. ROC curve analysis determined a cut-off value of 24 weeks’ GA. Nineteen percent of preterm SGA infants ≤32 weeks’ GA developed short stature treated with GH. A low GA at birth could be an early detection marker for short stature that requires GH treatment in preterm infants born SGA. |
format | Online Article Text |
id | pubmed-6706397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-67063972019-09-08 Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age Matsumoto, Masaaki Nagano, Nobuhiko Awano, Hiroyuki Ohyama, Shohei Fujioka, Kazumichi Iwatani, Sota Urakami, Tatsuhiko Iijima, Kazumoto Morioka, Ichiro Sci Rep Article Incidence and neonatal risk factors for short stature in preterm children born small for gestational age (SGA) have not been fully investigated in Japan. In this prospective study, infants born ≤32 weeks’ gestational age (GA) from 2004–2015 were enrolled and followed for 3 years. Incidence of short children born SGA and short stature treated with growth hormone (GH) were investigated. Neonatal risk factors were analysed using univariate and multivariate analyses. GA cut-off value was determined using receiver operating characteristic (ROC) curve analyses. Of 604 infants born ≤32 weeks’ GA, 76 (13%) were SGA at birth. Twenty-seven infants (36%) developed short stature at age 2 and 14 infants (19%) received GH treatment at age 3. GA, birthweight, birth length, birth head circumference, and chronic lung disease at 36 weeks’ corrected GA were determined as risk factors by univariate analyses (p < 0.01). Multivariate analyses only revealed low GA as an independent risk factor. ROC curve analysis determined a cut-off value of 24 weeks’ GA. Nineteen percent of preterm SGA infants ≤32 weeks’ GA developed short stature treated with GH. A low GA at birth could be an early detection marker for short stature that requires GH treatment in preterm infants born SGA. Nature Publishing Group UK 2019-08-22 /pmc/articles/PMC6706397/ /pubmed/31439925 http://dx.doi.org/10.1038/s41598-019-48785-y Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Matsumoto, Masaaki Nagano, Nobuhiko Awano, Hiroyuki Ohyama, Shohei Fujioka, Kazumichi Iwatani, Sota Urakami, Tatsuhiko Iijima, Kazumoto Morioka, Ichiro Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age |
title | Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age |
title_full | Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age |
title_fullStr | Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age |
title_full_unstemmed | Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age |
title_short | Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational Age |
title_sort | incidence and neonatal risk factors of short stature and growth hormone treatment in japanese preterm infants born small for gestational age |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706397/ https://www.ncbi.nlm.nih.gov/pubmed/31439925 http://dx.doi.org/10.1038/s41598-019-48785-y |
work_keys_str_mv | AT matsumotomasaaki incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage AT naganonobuhiko incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage AT awanohiroyuki incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage AT ohyamashohei incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage AT fujiokakazumichi incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage AT iwatanisota incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage AT urakamitatsuhiko incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage AT iijimakazumoto incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage AT moriokaichiro incidenceandneonatalriskfactorsofshortstatureandgrowthhormonetreatmentinjapanesepreterminfantsbornsmallforgestationalage |